There is no doubt that new weight loss drugs like Wegovy are revolutionising our treatment of obesity. After years of failing to help address the obesity epidemic, medicine finally has something to offer patients which appears to be effective.More drugs to compete with Wegovy — which contains semaglutide, the same active ingredient found in the type 2 medication Ozempic — are on the way, with Mounjaro already available from some pharmacies.Yet this isn’t the only thing these drugs might be able to help with. There’s increasing evidence that the group of medications that Wegovy and Ozempic belong to, called GLP-1 agonists, might also help people with other things, such as reducing their intake.
Load More
Load More